author-photo

Anne-Laure Taksin

44

Papers

1792

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia

2018 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (7)
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

2016 Leukemia
Show All
- Source
- Cite
- Save
Citations (77)
Azacitidine for the treatment of relapsed and refractory AML in older patients

2015 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (48)
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse

2014 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (18)
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

2012 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (15)
174 Does addition of erythropoietic stimulating agents (ESAs) improve the outcome of higher-risk MDS patients treated with azacitidine (AZA)?

2011 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
A Prospective Monocentric Study of Fractionated Gemtuzumab Ozogamicin (GO) Combined to Standard-Dose Cytarabine in Older Patients with Acute Myeloid Leukemia (AML) in First Relapse,

2011 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Azacitidine (AZA) After Failure of Lenalidomide (LEN) in Low/Int-1 Risk MDS with Del 5q

2011 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases

2011 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (33)